- Home
- MESA vs NRSN Comparison
MESA vs NRSN Comparison
Compare MESA & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- NRSN
- Stock Information
- Founded
- MESA 1982
- NRSN 2017
- Country
- MESA United States
- NRSN Israel
- Employees
- MESA N/A
- NRSN N/A
- Industry
- MESA Air Freight/Delivery Services
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- NRSN Health Care
- Exchange
- MESA Nasdaq
- NRSN Nasdaq
- Market Cap
- MESA 29.1M
- NRSN 26.0M
- IPO Year
- MESA 2018
- NRSN 2021
- Fundamental
- Price
- MESA $1.17
- NRSN $0.99
- Analyst Decision
- MESA
- NRSN Hold
- Analyst Count
- MESA 0
- NRSN 1
- Target Price
- MESA N/A
- NRSN N/A
- AVG Volume (30 Days)
- MESA 3.2M
- NRSN 130.1K
- Earning Date
- MESA 06-17-2025
- NRSN 04-07-2025
- Dividend Yield
- MESA N/A
- NRSN N/A
- EPS Growth
- MESA N/A
- NRSN N/A
- EPS
- MESA N/A
- NRSN N/A
- Revenue
- MESA $475,518,000.00
- NRSN N/A
- Revenue This Year
- MESA $15.09
- NRSN N/A
- Revenue Next Year
- MESA $16.19
- NRSN N/A
- P/E Ratio
- MESA N/A
- NRSN N/A
- Revenue Growth
- MESA N/A
- NRSN N/A
- 52 Week Low
- MESA $0.68
- NRSN $0.51
- 52 Week High
- MESA $1.89
- NRSN $1.50
- Technical
- Relative Strength Index (RSI)
- MESA 63.25
- NRSN 44.13
- Support Level
- MESA $1.05
- NRSN $0.97
- Resistance Level
- MESA $1.13
- NRSN $1.04
- Average True Range (ATR)
- MESA 0.10
- NRSN 0.09
- MACD
- MESA 0.03
- NRSN 0.00
- Stochastic Oscillator
- MESA 89.09
- NRSN 57.04
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.